German Leisure Stock News

TUI (XTRA:TUI1) has reported Q2 2026 revenue of €3.7b with a loss of €281.8m, or EPS of €0.56, setting a cautious tone after a profitable finish to 2025. The company has seen quarterly revenue move from €3.7b and EPS of €0.60 in Q2 2025 to €9.4b and EPS of €1.66 in Q4 2025, before easing back to €4.9b and EPS of €0.09 in Q1 2026. Investors are now weighing a fresh quarterly loss against trailing twelve month EPS of €1.38 as they assess how sustainable recent margin gains really look. See our...

RENK Group (XTRA:R3NK) is back in focus after confirming 2026 revenue guidance above €1.5b alongside its first quarter results, which showed sales of €283.61 million and net income of €15.35 million. See our latest analysis for RENK Group. Despite confirming revenue guidance above €1.5b, RENK Group’s recent momentum has softened, with the share price at €45.11, the 30 day share price return down 13.35%, and the 1 year total shareholder return down 18.41%. If you are weighing RENK Group’s...

Siemens Energy AG ( ETR:ENR ) missed earnings with its latest second-quarter results, disappointing overly-optimistic...

Last week saw the newest quarterly earnings release from 1&1 AG ( ETR:1U1 ), an important milestone in the company's...

Grand City Properties S.A. ( ETR:GYC ) shareholders are probably feeling a little disappointed, since its shares fell...

Verbio (XTRA:VBK) has just posted Q3 2026 results with revenue of €452.7 million and EPS of €0.36, set against a trailing twelve month picture that still shows a loss of €75.1 million on revenue of €1.8 billion and EPS of €1.18 in the red. Over recent quarters, revenue has moved from €395.3 million in Q2 2025 to €452.7 million in Q3 2026, while quarterly EPS has shifted from a loss of €0.06 in Q2 2025 to a profit of €0.36 in the latest period. This puts the focus firmly on how durable this...

Siemens Healthineers (XTRA:SHL) received FDA clearance in the US for six new Artis interventional imaging systems featuring the Optiq AI imaging chain with deep-learning-based noise reduction. The company also secured renewed CDC HoSt-TT program certification for its Atellica IM Testosterone II assay, confirming its measurement accuracy in hormone testing. For readers tracking medical technology, Siemens Healthineers sits at the intersection of advanced imaging and diagnostic testing, two...

First quarter earnings set the tone for Jungheinrich Jungheinrich (XTRA:JUN3) opened the new financial year with first quarter results showing sales of €1,272 million and net income of €26.2 million, both lower than the same period a year earlier. See our latest analysis for Jungheinrich. The Q1 earnings update has come against a weak share price backdrop, with Jungheinrich’s stock down 29.1% on a year to date share price return and the 1 year total shareholder return also declining 25.7%...

Ströer SE & Co. KGaA ( ETR:SAX ) last week reported its latest quarterly results, which makes it a good time for...

The European market has recently experienced a volatile period, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings, though tempered by tariff threats from the U.S. In this environment, dividend stocks can be an attractive option for investors seeking steady income streams and potential portfolio enhancement, especially as they offer a measure of stability against market fluctuations.

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

SBF AG ( FRA:CY1K ) is possibly approaching a major achievement in its business, so we would like to shine some light...

Last week, you might have seen that HOCHTIEF Aktiengesellschaft ( ETR:HOT ) released its first-quarter result to the...

Deutsche Lufthansa AG ( ETR:LHA ) just reported some strong earnings, and the market reacted accordingly with a healthy...

Logistri Fastighets (DB:6DV0) has opened 2026 with Q1 revenue of SEK52.1 million and net income of SEK52.4 million, setting a clear marker for its latest quarterly performance. The company has seen quarterly revenue move from SEK36.3 million in Q4 2024 to SEK40.6 million in Q1 2025 and SEK52.1 million in Q1 2026. Trailing 12 month net income has gone from SEK64.4 million at Q4 2024 to SEK157.7 million at Q1 2026, framing a results season where margins and earnings quality are front and center...

Deutsche Konsum Real Estate (XTRA:DKG) has reported Q2 2026 revenue of €24.3 million and basic EPS of €0.03, with net income excluding extra items at €2.9 million, giving investors a clean read on the latest quarter. Over recent periods the company has seen quarterly revenue move from €29.6 million in Q2 2025 to €24.3 million in Q2 2026. Basic EPS has ranged from a loss of €0.80 in Q3 2025 to €0.07 in Q1 2026 and €0.03 in the latest quarter, setting a mixed backdrop for how you assess the...

Q1 2026 earnings snapshot and what it means for Brenntag (XTRA:BNR) Brenntag (XTRA:BNR) opened 2026 with Q1 revenue of €3.7b and basic EPS of €0.68, setting a fresh reference point for investors lining up the latest numbers against a share price of €61.64. Over recent quarters the company has seen revenue move from €4.1b in Q1 2025 to €3.9b in Q4 2025 and then to €3.7b in Q1 2026, while quarterly basic EPS shifted from €0.93 to a loss of €0.20 and then to €0.68. With trailing net profit...

Siemens (XTRA:SIE) has just posted its Q2 2026 scorecard, with revenue of about €19.8b and net income from ongoing operations of €1.9b, translating into basic EPS of €2.48 for the quarter. The company has seen quarterly revenue move between about €18.4b and €21.4b and EPS range from €2.08 to €2.86 since early 2025, which gives a view of how the top line and per share earnings have tracked together. With trailing net profit margins slightly lower than a year ago, this set of results puts the...

JOST Werke (XTRA:JST) has just opened Q1 2026 with revenue of €417.0 million and basic EPS of €1.05, setting a clear marker for how the year is starting after a period of mixed profitability. Over recent quarters the company has seen revenue move from €373.7 million in Q1 2025 to €417.0 million in Q1 2026, with basic EPS ranging from €0.45 in Q2 2025 and €0.13 in Q3 2025 to €1.05 most recently. This gives investors a concrete trend line on both the top and bottom line as they weigh the latest...

Q1 2026 earnings snapshot MLP (XTRA:MLP) opened 2026 with Q1 total revenue of €314.8 million and basic EPS of €0.27, alongside net income of €29.8 million. The company has seen quarterly revenue move from €294.3 million and EPS of €0.25 in Q1 2025 through to €293.8 million and EPS of €0.10 in Q4 2025, before reaching the latest Q1 2026 levels. Trailing twelve month EPS stands at €0.53 on revenue of about €1.1 billion. With a trailing net profit margin of 5.4%, the focus now is on how durable...

Bertrandt (XTRA:BDT) has just posted Q2 2026 results with revenue of €222.7 million and a net loss of €16.4 million, which translates into EPS of €1.62 in the red. Over recent quarters the company has seen revenue move from €249.9 million and EPS of €1.10 in the red in Q2 2025 to €222.7 million with EPS of €1.62 in the red in Q2 2026. Trailing 12 month EPS sits at €5.76 in the red on €918.2 million of revenue. For investors, the picture is one of solid top line scale but compressed margins...

Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...

Dermapharm Holding (XTRA:DMP) has opened 2026 with Q1 revenue of €318.9 million and basic EPS of €0.84, setting the tone for how investors will read the latest earnings against the recent profitability reset. The company has seen quarterly revenue move from €305.3 million in Q1 2025 to €318.9 million in Q1 2026, while EPS over the same quarters shifted from €0.62 to €0.84. This sits alongside trailing 12 month earnings growth of 39.2% and a net margin that has improved to 12.2%, giving this...

RWE (XTRA:RWE) opened 2026 with Q1 revenue of €4.3b and net income of €20m, translating to basic EPS of €0.03, against a trailing twelve month EPS of €3.27 on revenue of €16.3b and net income of €2.4b. The company has seen quarterly revenue move from €6.4b in Q1 2025 to €4.3b in Q1 2026, while basic EPS shifted from €1.07 to €0.03 over the same period. Trailing margins settled at a net profit level of 14.5%, setting up this result as a test of how much short term earnings softness investors...